Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
04 mars 2021 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, March 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present...
Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
02 mars 2021 08h00 HE
|
Enzo Biochem, Inc.
Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results Company also publishes new corporate white...
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
01 mars 2021 16h05 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, March 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that it will report second...
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
03 févr. 2021 08h30 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the recent issuance of U.S....
ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
20 janv. 2021 08h14 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Enzo Board of...
ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
05 janv. 2021 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, today announced that it will participate in...
ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
04 janv. 2021 07h00 HE
|
Enzo Biochem, Inc.
- Use of pooled sampling with Enzo’s molecular diagnostic technology can help rapidly expand the number of people tested for COVID-19 - NEW YORK, NY, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzo...
ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES
28 déc. 2020 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that it has reviewed the...
Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
15 déc. 2020 08h00 HE
|
Enzo Biochem, Inc.
Thursday, December 17th @ 12:00pmET New York, NY, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that it will host...
Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
09 déc. 2020 16h01 HE
|
Enzo Biochem, Inc.
Company reports $28.7 million in revenue, exceeding revenue guidance by $1.7 million and representing a 47% increase over sequential quarter and continued recovery and opportunity from impact of...